CVS Caremark price target raised to $84-$89 from $75-$80 at Wells Fargo Wells Fargo increased its price target on CVS as the firm is more confident in the company's near-term and five-year financial targets following recent developments involving the company. Wells thinks that the stock is undervalued at current levels and keeps an Outperform rating on the shares.
News For CVS From The Last 14 Days
Check below for free stories on CVS the last two weeks.
CVS Caremark signs new affiliations with four major health care providers CVS Caremark has entered into new clinical affiliations with four major health care providers in Connecticut, Texas, South Carolina and Louisiana. Through these clinical affiliations the patients of these health care providers will receive access to clinical support, medication counseling, chronic disease monitoring and wellness programs at CVS/pharmacy stores and MinuteClinic, the retail health care division of CVS Caremark.